Autologous stem cell transplantation versus alternative allogeneic donor transplants in adult acute leukemias - ScienceDirect
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT - Biology of Blood and
Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia
Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects | Bone Marrow Transplantation
Cancers | Free Full-Text | Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?
Frontiers | Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics
Myeloid Malignancies | SpringerLink
The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O010 – O169) | Bone Marrow Transplantation
Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients? | Bone Marrow Transplantation
PDF) Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: A comparative study on behalf of the ALWP of the
Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working
PDF) The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working
The EBMT risk score | Bone Marrow Transplantation
JCM | Free Full-Text | Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
JCM | Free Full-Text | Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?
Autologous stem cell transplantation for acute myeloid leukemia | Bone Marrow Transplantation
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for
AML Hub on Twitter: "#EHA23 Great presentation on the first predictive score for LFS in acute myeloid leukemia patients treated with ASCT by Roni Shouval from @SHEBA_ @TheEBMT #leusm #AML https://t.co/aVt58AngCJ" /
Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation - ScienceDirect
PDF) Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation | Haematologica
Autologous Hematopoietic Stem Cell Transplantation in Acute Myelogenous Leukemia
EBMT Handbook of HSCT | PDF | Hematopoietic Stem Cell Transplantation | Bone Marrow
